|Bid||1.6900 x 1400|
|Ask||1.7000 x 800|
|Day's Range||1.6700 - 1.7375|
|52 Week Range||1.5100 - 8.7500|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
LOS ANGELES, August 10, 2022--ChromaDex Corp. (NASDAQ:CDXC) today announced financial results for the second quarter of 2022.
LOS ANGELES, August 02, 2022--ChromaDex Corp. (NASDAQ:CDXC) announced that it will hold a conference call on Wed. August 10, 2022 at 4:30 p.m. ET to discuss its financial results for the second quarter, which ended June 30, 2022. The financial results will be reported in a press release after the close of regular stock market trading hours on the same day as the conference call.
LOS ANGELES, July 07, 2022--ChromaDex Corp. (NASDAQ:CDXC) today announced that it will host a key opinion leader (KOL) webinar on the transforming benefits of nicotinamide riboside (NR) on Wednesday, July 20, 2022 at 11:00 am Eastern Time.